Finzati - Logo
CUPR logo

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

CUPRBiotechnology
$3.16
+0.22 (+7.48%)
Current price
EarningsLatest report: Dec 31, 2025
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$8.47M
Growth
-3.9%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.1Healthy liquidity · 2.35Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$3.16
Change7.48%
Shares Out2.68M
Market Cap$8.47M
52W Range1.76 - 76.00
Beta-1.09
P/E-1.24
P/S116.17
P/B1.15
P/FCF-0.63
EV/Sales158.20
EV/EBITDA-1.73

Investment DNA

How strong this company looks for long-term investors

35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
53/100
Why this score
Manageable debt level · 0.1Healthy liquidity · 2.35Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 4/10/2025
Industry: Biotechnology
P/B i: 1.15
Debt / Equity i: 0.10
Operating Margin: -9154.62%
Net Margin: -9366.75%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.10
Current Ratio: 2.35
Quick Ratio: 2.35
Status: Good

Insider Transactions

Recent executive and insider activity

LEE Jimmy Peng Siew
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/21/2026
Type
OTHER
RAINA Natasha Kaur
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/21/2026
Type
OTHER
TEO Peng Kwang
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/21/2026
Type
OTHER